Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$40.00 USD
-0.16 (-0.40%)
Updated Sep 20, 2024 03:53 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO11/11/24 |
---|---|
Current Quarter | -0.15 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | -23.08% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.99 |
Next Year | 4.61 |
EPS (TTM) | -1.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 49.98M | 54.64M | 182.86M | 337.92M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 52.07M | 57.92M | 190.74M | 443.04M |
Low Estimate | 47.06M | 51.54M | 171.58M | 279.98M |
Year ago Sales | 27.25M | 42.45M | 113.63M | 182.86M |
Year over Year Growth Est. | 83.41% | 28.72% | 60.93% | 84.80% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.15 | 0.12 | -0.99 | 4.61 |
# of Estimates | 3 | 4 | 2 | 2 |
Most Recent Consensus | 0.07 | 0.15 | -0.47 | 1.62 |
High Estimate | 0.12 | 0.24 | -0.68 | 6.32 |
Low Estimate | -0.36 | -0.04 | -1.29 | 2.90 |
Year ago EPS | -0.58 | -0.06 | -1.64 | -0.99 |
Year over Year Growth Est. | 74.14% | 300.00% | 39.63% | 565.15% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.15 | 0.12 | -0.99 | 4.61 |
7 Days Ago | -0.15 | 0.12 | -0.99 | 4.61 |
30 Days Ago | -0.15 | 0.12 | -0.99 | 4.61 |
60 Days Ago | -0.10 | 0.24 | -0.70 | 4.65 |
90 Days Ago | -0.10 | 0.24 | -0.70 | 4.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | 0.12 | -0.99 | 4.61 |
Zacks Consensus Estimate | -0.15 | 0.12 | -0.99 | 4.61 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.88 | -0.06 | -0.58 | NA |
Estimate | -0.13 | -0.14 | -0.10 | -0.22 | NA |
Difference | -0.03 | -0.74 | 0.04 | -0.36 | -0.27 |
Surprise | -23.08% | -528.57% | 40.00% | -163.64% | -168.82% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more